Evidence map›Paper›PMID 25144194›Full record

Observational studyPloS one2014

The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study.

Godfrey Kigozi, Richard Musoke, Stephen Watya, Nehemia Kighoma, James Nkale, Mary Nakafeero, Dan Namuguzi, David Serwada, Fred Nalugoda, Nelson Sewankambo and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.Journal of acquired immune deficiency syndromes (1999) · 2016
    Article
  20. Ockham's Razor and the PrePex Male Circumcision Device.The Journal of infectious diseases · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Godfrey KigoziRakai Health Sciences Program, Entebbe, Uganda.
Richard MusokeRakai Health Sciences Program, Entebbe, Uganda.
Stephen WatyaRakai Health Sciences Program, Entebbe, Uganda.
Nehemia KighomaRakai Health Sciences Program, Entebbe, Uganda.
James NkaleRakai Health Sciences Program, Entebbe, Uganda.
Mary NakafeeroRakai Health Sciences Program, Entebbe, Uganda.
Dan NamuguziDepartment of Urology, Mulago Hospital, Kampala, Uganda.
David SerwadaRakai Health Sciences Program, Entebbe, Uganda; School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Fred NalugodaRakai Health Sciences Program, Entebbe, Uganda.
Nelson SewankamboRakai Health Sciences Program, Entebbe, Uganda; College of Health Sciences, Makerere University, Kampala, Uganda.
Maria Joan WawerRakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Ronald Henry GrayRakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Rakai Health Sciences Program · UGJohns Hopkins University · USMulago Hospital · UGUniversity of Bahrain · BH

Funding

Circumcision: HIV/STIs and behaviors in a RCT and post-RCT surveillance; RakaiU01AI075115 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2007 to 2011
$9.3M
NIAID NIH HHS U01 AI075115-0451
6 · The paper itself

Abstract

objectivesTo assess the safety and acceptance of the PrePex device for medical male circumcision (MMC) in rural Uganda.

methodsIn an observational study, HIV-uninfected, uncircumcised men aged 18 and older who requested elective MMC were informed about the PrePex and dorsal slit methods and offered a free choice of their preferred procedure. 100 men received PrePex to assess preliminary safety (aim 1). An additional 329 men, 250 chose PrePex and 79 chose Dorsal slit, were enrolled following approval by the Safety Monitoring Committee (aim 2). Men were followed up at 7 days to assess adverse events (AEs) and to remove the PrePex device. Wound healing was assessed at 4 weeks, with subsequent weekly follow up until completed healing.

resultsThe PrePex device was contraindicated in 5.7% of men due to a tight prepuce or phimosis/adhesions. Among 429 enrolled men 350 (82.0%) got the PrePex device and 79 (18.0%) the dorsal slit procedure. 250 of 329 men (76.0%) who were invited to choose between the 2 procedures chose Prepex. There were 9 AEs (2.6%) with the PrePex, of which 5 (1.4%) were severe complications, 4 due to patient self-removal of the device leading to edema and urinary obstruction requiring emergency surgical circumcision, and one due to wound dehiscence following device removal. 71.8% of men reported an unpleasant odor prior to PrePex removal. Cumulative rates of completed wound healing with the PrePex were 56.7% at week 4, 84.8% week 5, 97.6% week 6 and 98.6% week 7, compared to 98.7% at week 4 with dorsal slit (p<0.0001).

conclusionThe PrePex device was well accepted, but healing was slower than with dorsal slit surgery. Severe complications, primarily following PrePex self-removal, required rapid access to emergency surgical facilities. The need to return for removal and delayed healing may increase Program cost and client burden.

Indexed as

Circumcision, MaleAdolescentAdultHumansMaleUgandaWound HealingYoung Adult

Identifiers

PMID25144194
PMCPMC4140666
OpenAlexW2062044882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.